Skip to main content
  • Mediso receives FDA approval for InterView™ nuclear medicine image processing software

    BUDAPEST, Hungary, June 21, 2023 /PRNewswire/ -- Mediso has announced the Food and Drug Administration (FDA) clearance of the InterView™ FUSION and InterView™ XP multimodality (PET/SPECT/MRI/CT) image processing and reporting software which is specifically adapted for nuclear medicine and molecular imaging workflows.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details